Incyte Corporation

As of June 30, 2026, Incyte Corporation Shs Unsponsored Brazilian Depositary Receipt Repr 0.5 Sh carries a market capitalization of 119.60B, placing it among publicly traded companies globally. Its enterprise value stands at 96.35B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Incyte Corporation Shs Unsponsored Brazilian Depositary Receipt Repr 0.5 Sh's next confirmed earnings release is scheduled for October 29, 2026.

As of June 30, 2026, Incyte Corporation Shs Unsponsored Brazilian Depositary Receipt Repr 0.5 Sh has 408.46M shares outstanding.

As of June 30, 2026, Incyte Corporation Shs Unsponsored Brazilian Depositary Receipt Repr 0.5 Sh trades at a trailing price-to-earnings ratio of 14.15. The price-to-sales ratio is 3.92, and the price-to-book ratio stands at 3.65.

As of June 30, 2026, Incyte Corporation Shs Unsponsored Brazilian Depositary Receipt Repr 0.5 Sh trades at an EV/EBITDA multiple of 9.93 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 3.20 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 10.48 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. Incyte Corporation Shs Unsponsored Brazilian Depositary Receipt Repr 0.5 Sh trades at an EV/FCF ratio of 9.55, comparing the total takeover cost of the business to the cash it actually generates for all capital providers. These enterprise value multiples are built on an enterprise value of 96.35B versus a market cap of 119.60B, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Incyte Corporation Shs Unsponsored Brazilian Depositary Receipt Repr 0.5 Sh maintains a current ratio of 4.59, meaning it holds 4.6x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 0.60, indicating moderate leverage, while an interest coverage ratio of 807.17 demonstrates strong ability to service its debt obligations.

Over the twelve months ended June 30, 2026, Incyte Corporation Shs Unsponsored Brazilian Depositary Receipt Repr 0.5 Sh posted a return on equity (ROE) of 30.67, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 27.49 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 23.55, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 30.47, useful for judging operating efficiency across full business cycles. The company generates approximately 10.79M in revenue per employee across its workforce of 2,787.25, a quick read on workforce productivity versus industry peers. Inventory turnover of 4.38 indicates how many times Incyte Corporation Shs Unsponsored Brazilian Depositary Receipt Repr 0.5 Sh sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, Incyte Corporation Shs Unsponsored Brazilian Depositary Receipt Repr 0.5 Sh recorded 1.83B in income tax expense. That works out to an effective tax rate of 18.04, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 10.17B, leaving 8.33B in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 23, 2026, Incyte Corporation Shs Unsponsored Brazilian Depositary Receipt Repr 0.5 Sh's stock has gained approximately 25.96% over the past 52 weeks. The 50-day moving average sits at 270.82, while the 200-day moving average is 234.48.

Over the twelve months ended June 30, 2026, Incyte Corporation Shs Unsponsored Brazilian Depositary Receipt Repr 0.5 Sh generated 30.08B in revenue and converted that into 8.33B in net income, yielding earnings per share of 19.97. EBITDA reached 9.70B, while operating income came in at 9.51B.

As of June 30, 2026, Incyte Corporation Shs Unsponsored Brazilian Depositary Receipt Repr 0.5 Sh holds 23.45B in cash and equivalents against 197.80M in total debt, resulting in a net debt position of -20.58B. Total book value stands at 32.79B, with working capital of 24.37B providing operational flexibility.

Incyte Corporation Shs Unsponsored Brazilian Depositary Receipt Repr 0.5 Sh produced 10.23B in operating cash flow over the twelve months ended June 30, 2026. After subtracting -155.07M in capital expenditures, free cash flow totaled 10.08B - equivalent to 25.02 per share.

Over the twelve months ended June 30, 2026, Incyte Corporation Shs Unsponsored Brazilian Depositary Receipt Repr 0.5 Sh posted a gross margin of 92.62, reflecting its pricing power and cost economics. The operating margin of 31.61 and net profit margin of 27.71 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2026. Free cash flow yield stands at 8.25, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield is negative at -1.19, meaning Incyte Corporation Shs Unsponsored Brazilian Depositary Receipt Repr 0.5 Sh raised more capital through share issuance and new debt than it returned via dividends and buybacks.

As of June 30, 2026, Incyte Corporation Shs Unsponsored Brazilian Depositary Receipt Repr 0.5 Sh has an Altman Z-Score of 11.58, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.